Literature DB >> 11795279

Lysophosphatidylcholine inhibits T cell-specific CXC chemokines IP-10, MIG, and I-TAC expression induced by IFN-gamma in human endothelial cells.

A M Sheikh1, H Ochi, J Masuda.   

Abstract

Hypercholesterolemia is reported to be associated with a T helper (Th) 1 to Th2 switch in apoE-deficient mice. To explore the underlying mechanisms of such immune modulation, we investigated if lysophosphatidylcholine (Lyso-PC), enriched in oxidized LDL, affects cytokine-induced expression of Th1 cell-specific CXC chemokines, IFN-inducible protein of 10 kDa (IP-10), monokine induced by IFN-gamma (Mig), and IFN-inducible T cell a chemoattractant (1-TAC) in cultured endothelial cells. Lyso-PC inhibited IFN-gamma or IFN-gamma plus TNF-alpha-induced IP-10, Mig, and I-TAC mRNA expression but not that of the IRF-1 or IRF-1 dependent molecule, GBP. It also inhibited IP-10 protein secretion in conditioned media induced by IFN-gamma or IFN-y plus TNF-alpha Western analysis demonstrated that Lyso-PC inhibited IFN-gamma-induced STAT-1alpha protein expression, but not that of IRF-1. These results suggest that Lyso-PC selectively inhibits IP-10, Mig, and I-TAC expression through IRF-1-independent mechanisms. This inhibitory effect of Lyso-PC may be involved in the immune modulation by hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11795279     DOI: 10.1111/j.1749-6632.2001.tb03952.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes.

Authors:  G-Y Gwak; J-H Yoon; S-H Lee; S-M Lee; H-S Lee; G J Gores
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

2.  Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells.

Authors:  Rafael Corrêa; Luís Felipe Fonseca Silva; Dalila Juliana Silva Ribeiro; Raquel das Neves Almeida; Igor de Oliveira Santos; Luís Henrique Corrêa; Lívia Pimentel de Sant'Ana; Leonardo Santos Assunção; Patrícia T Bozza; Kelly Grace Magalhães
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.